Navigation Links
Novel Investigational Drug May Help American Women Suffering from Breast Pain

A clinical trial for a much needed treatment option for pain associated with fibrocystic breast disease, is in progress nationwide. The severely debilitating symptoms such as breast pain, affects about 26 million women in the United States alone but is often left untreated leaving women feeling hopeless.

As many as 50% of American women talk to their physician about breast pain including swelling, tenderness and lumps that increase prior and during menstruation and may continue for several days. The pain is not only physical. Psychological stress is often associated with undergoing mammograms, ultrasound scans and breast biopsies, techniques frequently utilized by physicians to rule out other diseases of the breast.

"Breast pain associated with fibrocystic breast disease can be physically impairing, leaving women unable to cope with basic daily functions, yet 85% of women don't receive treatment," said Gerianne Tringali DiPiano, President and CEO of FemmePharma Global Healthcare, the company sponsoring the study. "We hope news of this trial will compel women with breast pain associated with fibrocystic breast disease who have been previously diagnosed to seek a study center in their area."

Physicians at centers nationwide will enroll women who have breast pain associated with fibrocystic breast disease.

"The trial allows us to assess a new dosage form of an active pharmaceutical ingredient with a demonstrated safety and efficacy profile. We expect that the new dosage forms will provide a new treatment option for this very important disease state," added Bruce J. Levine MD, FACOG, and investigator of the trial.

About Breast Pain

Breast pain can impair a woman's ability to work, participate in her daily activities, embrace a child or have an intimate relationship with her partner. In addition, breast pain frequently causes increased anxiety and stress in a woman's life as a res ult of dealing with pain each month.

Approximately 15% of women who experience breast pain require prescription medication. Currently there is only one FDA approved prescription medication for pain associated with fibrocystic breast disease. However, this medication typically produces unwanted systemic side effects, which often causes women to stop their necessary treatment. In many cases, women are sent home and told to ice their breasts or purchase a tighter fitting brassiere leaving them feeling hopeless.


'"/>




Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/5/2016)... ... May 05, 2016 , ... Florida Hospital Pepin Heart ... fibrillation (A-Fib) an alternative to long-term warfarin medication with the newly approved WATCHMAN ... of 2015, Florida Hospital Pepin Heart Institute doctors successfully implanted the Watchman device ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... the Wharton Seminars for Business Journalists , led by the Wharton ... business and economic issues.  This one-day program at the Wharton School’s San ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... in all U.S. states and certain Canadian provinces is now available from the ... Research Institute (WCRI). , The report, Workers’ Compensation Laws as of ...
(Date:5/5/2016)... ... May 05, 2016 , ... Tim Dieter has ... families of greater Dubuque, IA. The current campaign fundraises for Veteran’s Freedom Center ... Donations to Veteran’s Freedom Center may now be made here: http://www.veteransfreedomcenter.com/donate/ . ...
(Date:5/5/2016)... ... 05, 2016 , ... Dr. Benjamin Stong of Kalos Facial Plastic Surgery, LLC ... Stong is double board certified and the only facial plastic surgeon in Atlanta to ... Non-surgical therapies such as stem cells can be used to provide stabilization to hair ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... 2016 Research and Markets has announced the ... 5 EU Markets"  report to their offering.  ,     (Logo: ... on the current Positron Emission Tomography (PET) scanner and cyclotron ... which includes France , Germany ... and the United Kingdom . ...
(Date:5/5/2016)... 2016 Research and ... Thalassaemia Market and Competitive Landscape Highlights - ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ... Competitive Landscape Highlights - 2016, provides comprehensive ... Thalassaemia market valuations and forecast, Thalassaemia products ...
(Date:5/4/2016)... , May 4, 2016 ... Market Research entitled "Brain Computer Interface Market - Global Industry ... 2024," the  global brain computer interface (BCI) market  is expected ... The market is estimated to expand at a CAGR ... to 2024. A BCI device provides collaboration ...
Breaking Medicine Technology: